世界のジフテリア・破傷風・百日咳(DTaP)ワクチン市場:販売動向2019

QYResearchが発行した調査報告書(DATA907A2804)
◆英語タイトル:Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Report 2019
◆商品コード:DATA907A2804
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年7月(※2024年版があります。お問い合わせください。)
◆ページ数:110
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ジフテリア・破傷風・百日咳(DTaP)ワクチンの世界市場について調査・分析し、ジフテリア・破傷風・百日咳(DTaP)ワクチンのメーカー別販売量、市場シェア分析、種類別販売分析(免疫用DTaPワクチン、治療用DTaPワクチン)、用途別販売分析(Adult、Pediatric)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・ジフテリア・破傷風・百日咳(DTaP)ワクチン市場概要
・ジフテリア・破傷風・百日咳(DTaP)ワクチンのメーカー別販売量・メーカー別シェア
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの種類別販売量(免疫用DTaPワクチン、治療用DTaPワクチン)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの用途別販売量(Adult、Pediatric)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの地域別販売量・市場シェア
・ジフテリア・破傷風・百日咳(DTaP)ワクチンのアメリカ市場規模(2014年-2019年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンのヨーロッパ市場規模(2014年-2019年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの中国市場規模(2014年-2019年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの日本市場規模(2014年-2019年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの東南アジア市場規模(2014年-2019年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンのインド市場規模(2014年-2019年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンメーカー分析(企業概要、製品概要、販売量、売上、価格等)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンのコスト分析
・ジフテリア・破傷風・百日咳(DTaP)ワクチン販売チャネル、流通業者、顧客
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの世界市場動向・機会・成長要因・課題
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの種類別世界市場予測(免疫用DTaPワクチン、治療用DTaPワクチン)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの用途別世界市場予測(Adult、Pediatric)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンのアメリカ市場予測(2019年-2025年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンのヨーロッパ市場予測(2019年-2025年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの中国市場予測(2019年-2025年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの日本市場予測(2019年-2025年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンの東南アジア市場予測(2019年-2025年)
・ジフテリア・破傷風・百日咳(DTaP)ワクチンのインド市場予測(2019年-2025年)
...
【レポートの概要】

DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP’s narrower antigen base is less effective against current pathogen strains.
The global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market status and forecast, categorizes the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Immune DTaP Vaccine
Therapy DTaP Vaccine

Segment by Application
Adult
Pediatric

【レポートの目次】

Table of Contents

Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Report 2019
1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Overview
1.1 Diphtheria, Tetanus, and Pertussis (DTaP) VaccineProduct Overview
1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Type
1.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Comparison by Types (2014-2025)
1.2.2 Immune DTaP Vaccine
1.2.3 Therapy DTaP Vaccine
1.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Application
1.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Comparison by Application (2014-2025)
1.3.1 Adult
1.3.2 Pediatric
1.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market by Region
1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Comparison by Region (2014-2025)
1.4.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.4 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.5 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.6 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.7 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue (2014-2025)
1.5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Growth Rate (2014-2025)
1.5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue and Growth Rate (2014-2025)

2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Company, Region, Type and Application
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Competition by Companies
2.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Company (2014-2019)
2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue by Region
2.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Region (2014-2019)
2.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Region (2014-2019)
2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue by Type
2.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
2.3.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type (2014-2019)
2.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application

3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
3.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue (2014-2019)
3.1.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
3.1.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
3.1.3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
3.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
3.3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
3.4 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application

4 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
4.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Value (2014-2019)
4.1.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
4.1.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
4.1.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
4.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
4.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
4.4 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application

5 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
5.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue (2014-2019)
5.1.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
5.1.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
5.1.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
5.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
5.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
5.4 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application

6 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
6.1 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Value (2014-2019)
6.1.1 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
6.1.2 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
6.1.3 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
6.2 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
6.3 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
6.4 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application

7 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
7.1 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Value (2014-2019)
7.1.1 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
7.2 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
7.3 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
7.4 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application

8 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
8.1 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Value (2014-2019)
8.1.1 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
8.1.2 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
8.1.3 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
8.2 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
8.3 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
8.4 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application

9 Company Profiles and Key Figures in Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Business
9.1 Sanofi Pasteur
9.1.1 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Protein Sciences Corporation
9.3.1 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.3.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Novartis AG
9.4.1 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.4.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Seqirus
9.5.1 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.5.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Merck Sharp & Dohme Corp
9.6.1 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.6.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Astellas Pharma US, Inc
9.7.1 Astellas Pharma US, Inc Production Sites and Area Served
9.7.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.7.3 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Pfizer Inc
9.8.1 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.8.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Johnson & Johnson
9.9.1 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.9.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served
9.10 Lanzhou Institute of Biological Products Co., Ltd
9.10.1 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.10.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business and Markets Served
9.11 AstraZeneca
9.12 Emergent BioSolutions Inc

10 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Maufacturing Cost Analysis
10.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
11.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Forecast
13.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price Forecast
13.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Forecast (2019-2025)
13.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Forecast (2019-2025)
13.1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend Forecast (2019-2025)
13.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast by Region
13.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast by Type
13.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type (2019-2025)
13.3.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Type (2019-2025)
13.3.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Forecast by Type (2019-2025)
13.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のジフテリア・破傷風・百日咳(DTaP)ワクチン市場:販売動向2019(Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Report 2019)]についてメールでお問い合わせはこちらでお願いします。